1. Home
  2. CBAN vs ENTA Comparison

CBAN vs ENTA Comparison

Compare CBAN & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$19.47

Market Cap

436.6M

Sector

Finance

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.57

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAN
ENTA
Founded
1975
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
436.6M
374.6M
IPO Year
1995
2012

Fundamental Metrics

Financial Performance
Metric
CBAN
ENTA
Price
$19.47
$14.57
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
320.6K
100.1K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
2.44%
N/A
EPS Growth
16.91
29.93
EPS
1.59
N/A
Revenue
N/A
$102,814,000.00
Revenue This Year
$35.41
$7.76
Revenue Next Year
$4.84
N/A
P/E Ratio
$12.47
N/A
Revenue Growth
N/A
16.48
52 Week Low
$14.63
$4.96
52 Week High
$21.61
$17.15

Technical Indicators

Market Signals
Indicator
CBAN
ENTA
Relative Strength Index (RSI) 37.91 61.80
Support Level $19.12 $13.75
Resistance Level $21.21 $15.37
Average True Range (ATR) 0.51 0.64
MACD -0.16 0.06
Stochastic Oscillator 6.90 81.88

Price Performance

Historical Comparison
CBAN
ENTA

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: